Stockreport

ProMIS Neurosciences Issues Letter to Shareholders

ProMIS Neurosciences Inc. - Common Shares  (PMN) 
PDF CAMBRIDGE, Massachusetts, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the gen [Read more]